|
1
|
Mohsen L, Abou-Alam M, El-Dib M, Labib M,
Elsada M and Aly H: A prospective study on hyperglycemia and
retinopathy of prematurity. J Perinatol. 34:453–457. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ghosh SS, Righi S, Krieg R, Kang L, Carl
D, Wang J, Massey HD, Sica DA, Gehr TW and Ghosh S: High fat high
cholesterol diet (western diet) aggravates atherosclerosis,
hyperglycemia and renal failure in nephrectomized LDL receptor
knockout mice: role of intestine derived lipopolysaccharide. PLoS
One. 10:e01411092015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Laakso M and Kuusisto J: Insulin
resistance and hyperglycaemia in cardiovascular disease
development. Nat Rev Endocrinol. 10:293–302. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cal L, Li W, Wang G, Guo L, Jiang Y and
Kang YJ: Hypergly cemia-induced apoptosis in mouse myocardium:
Mitochondrial cytochrome C-mediated caspase-3 activation pathway.
Diabetes. 51:1938–1948. 2002. View Article : Google Scholar
|
|
5
|
Suzuki K, Olah G, Modis K, Coletta C, Kulp
G, Gerö D, Szoleczky P, Chang T, Zhou Z, Wu L, et al: Hydrogen
sulfide replacement therapy protects the vascular endothelium in
hyperglycemia by preserving mitochondrial function. Proc Natl Acad
Sci USA. 108:13829–13834. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Degterev A, Huang Z, Boyce M, Li Y, Jagtap
P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA and Yuan J:
Chemical inhibitor of nonapoptotic cell death with therapeutic
potential for ischemic brain injury. Nat Chem Biol. 1:112–119.
2005. View Article : Google Scholar
|
|
7
|
Han J, Zhong CQ and Zhang DW: Programmed
necrosis: Backup to and competitor with apoptosis in the immune
system. Nat Immunol. 12:1143–1149. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Smith CC and Yellon DM: Necroptosis,
necrostatins and tissue injury. J Cell Mol Med. 15:1797–1806. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dvoriantchikova G, Degterev A and Ivanov
D: Retinal ganglion cell (RGC) programmed necrosis contributes to
ischemia-reperfusion-induced retinal damage. Exp Eye Res. 123:1–7.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oerlemans MI, Liu J, Arslan F, den Ouden
K, van Middelaar BJ, Doevendans PA and Sluijter JP: Inhibition of
RIP1-dependent necrosis prevents adverse cardiac remodeling after
myocardial ischemia-reperfusion in vivo. Basic Res Cardiol.
107:2702012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao W, Zhang J, Lu Y and Wang R: The
vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP)
channel opener. EMBO J. 20:6008–6016. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang G, Wu L, Jiang B, Yang W, Qi J, Cao
K, Meng Q, Mustafa AK, Mu W, Zhang S, et al: H2S as a
physiologic vasorelaxant: Hypertension in mice with deletion of
cystathionine gammalyase. Science. 322:587–590. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Papapetropoulos A, Pyriochou A, Altaany Z,
Yang G, Marazioti A, Zhou Z, Jeschke MG, Branski LK, Herndon DN,
Wang R, et al: Hydrogen sulfide is an endogenous stimulator of
angiogenesis. Proc Natl Acad Sci USA. 106:21972–21977. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Calvert JW, Elston M, Nicholson CK,
Gundewar S, Jha S, Elrod JW, Ramachandran A and Lefer DJ: Genetic
and pharmacologic hydrogen sulfide therapy attenuates
ischemia-induced heart failure in mice. Circulation. 122:11–19.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang X, Wang Q, Guo W and Zhu YZ: Hydrogen
sulfide attenuates cardiac dysfunction in a rat model of heart
failure: A mechanism through cardiac mitochondrial protection.
Biosci Rep. 31:87–98. 2011. View Article : Google Scholar
|
|
16
|
Xu W, Wu W, Chen J, Guo R, Lin J, Liao X
and Feng J: Exogenous hydrogen sulfide protects H9c2 cardiac cells
against high glucose-induced injury by inhibiting the activities of
the p38 MAPK and ERK1/2 pathways. Int J Mol Med. 32:917–925. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang XY, Yang CT, Zheng DD, Mo LQ, Lan AP,
Yang ZL, Hu F, Chen PX, Liao XX and Feng JQ: Hydrogen sulfide
protects H9c2 cells against doxorubicin-induced cardiotoxicity
through inhibition of endoplasmic reticulum stress. Mol Cell
Biochem. 363:419–426. 2012. View Article : Google Scholar
|
|
18
|
Xu W, Chen J, Lin J, Liu D, Mo L, Pan W,
Feng J, Wu W and Zheng D: Exogenous H2S protects H9c2
cardiac cells against high glucose-induced injury and inflammation
by inhibiting the activation of the NF-κB and IL-1β pathways. Int J
Mol Med. 35:177–186. 2015. View Article : Google Scholar
|
|
19
|
Liang W, Chen J, Mo L, Ke X, Zhang W,
Zheng D, Pan W, Wu S, Feng J, Song M, et al: ATP-sensitive
K+ channels contribute to the protective effects of
exogenous hydrogen sulfide against high glucose-induced injury in
H9c2 cardiac cells. Int J Mol Med. 37:763–772. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mani S, Li H, Untereiner A, Wu L, Yang G,
Austin RC, Dickhout JG, Lhoták Š, Meng QH and Wang R: Decreased
endogenous production of hydrogen sulfide accelerates
atherosclerosis. Circulation. 127:2523–2534. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang H, Guo C, Wu D, Zhang A, Gu T, Wang
L and Wang C: Hydrogen sulfide inhibits the development of
atherosclerosis with suppressing CX3CR1 and CX3CL1 expression. PLoS
One. 7:e411472012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jain SK, Bull R, Rains JL, Bass PF, Levine
SN, Reddy S, McVie R and Bocchini JA Jr: Low levels of hydrogen
sulfide in the blood of diabetes patients and
streptozotocin-treated rats causes vascular inflammation? Antioxid
Redox Signal. 12:1333–1337. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu YS, Huang ZW, Wang L, Liu XX, Wang YM,
Zhang Y and Zhang M: Sitagliptin alleviated myocardial remodeling
of the left ventricle and improved cardiac diastolic dysfunction in
diabetic rats. J Pharmacol Sci. 127:260–274. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin J, Li H, Yang M, Ren J, Huang Z, Han
F, Huang J, Ma J, Zhang D, Zhang Z, et al: A role of RIP3-mediated
macrophage necrosis in atherosclerosis development. Cell Reports.
3:200–210. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han W, Xie J, Li L, Liu Z and Hu X:
Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis.
Apoptosis. 14:674–686. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ruderman NB, Williamson JR and Brownlee M:
Glucose and diabetic vascular disease. FASEB J. 6:2905–2914. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
van Dieren S, Beulens JW, van der Schouw
YT, Grobbee De and Neal B: The global burden of diabetes and its
complications: An emerging pandemic. Eur J Cardiovasc Prev Rehabil.
17(Suppl 1): S3–S8. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kern TS, Tang J, Mizutani M, Kowluru RA,
Nagaraj RH, Romeo G, Podesta F and Lorenzi M: Response of capillary
cell death to aminoguanidine predicts the development of
retinopathy: Comparison of diabetes and galactosemia. Invest
Ophthalmol Vis Sci. 41:3972–3978. 2000.PubMed/NCBI
|
|
29
|
Zhang X, Liang D, Lian X, Jiang Y, He H,
Liang W, Zhao Y and Chi ZH: Berberine activates Nrf2 nuclear
translocation and inhibits apoptosis induced by high glucose in
renal tubular epithelial cells through a phosphatidylinositol
3-kinase/Akt-dependent mechanism. Apoptosis. 21:721–736. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Frustaci A, Kajstura J, Chimenti C,
Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B and Anversa P:
Myocardial cell death in human diabetes. Circ Res. 87:1123–1132.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kung G, Konstantinidis K and Kitsis RN:
Programmed necrosis, not apoptosis, in the heart. Circ Res.
108:1017–1036. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
He S, Wang L, Miao L, Wang T, Du F, Zhao L
and Wang X: Receptor interacting protein kinase-3 determines
cellular necrotic response to TNF-alpha. Cell. 137:1100–1111. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cho YS, Challa S, Moquin D, Genga R, Ray
TD, Guildford M and Chan FK: Phosphorylation-driven assembly of the
RIP1-RIP3 complex regulates programmed necrosis and virus-induced
inflammation. Cell. 137:1112–1123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Declercq W, Vanden Berghe T and
Vandenabeele P: RIP kinases at the crossroads of cell death and
survival. Cell. 138:229–232. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Smith CC, Davidson SM, Lim SY, Simpkin JC,
Hothersall JS and Yellon DM: Necrostatin: A potentially novel
cardioprotective agent. Cardiovasc Drugs Ther. 21:227–233. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Holler N, Zaru R, Micheau O, Thome M,
Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B and Tschopp
J: Fas triggers an alternative, caspase-8-independent cell death
pathway using the kinase RIP as effector molecule. Nat Immunol.
1:489–495. 2000. View
Article : Google Scholar
|
|
37
|
Zhang N, Chen Y, Jiang R, Li E, Chen X, Xi
Z, Guo Y, Liu X, Zhou Y, Che Y, et al: PARP and RIP 1 are required
for autophagy induced by 11′-deoxyverticillin A, which precedes
caspase-dependent apoptosis. Autophagy. 7:598–612. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu S, Liu Z and Liu P: Targeting hydrogen
sulfide as a promising therapeutic strategy for atherosclerosis.
Int J Cardiol. 172:313–317. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mani S, Untereiner A, Wu L and Wang R:
Hydrogen sulfide and the pathogenesis of atherosclerosis. Antioxid
Redox Signal. 20:805–817. 2014. View Article : Google Scholar
|
